Thank you for your query at DoctorSpring.com
The standard treatment for AML subtype will be a 3 + 7 regime, consisting of daunorubicin and cytarabine.
Institutions prefer varying regimen and dosages based on preferences and their experience in the management.
AML treatment requires a lot of blood support and transfusion.
You can discuss the ongoing treatment protocol with your Oncologist.
Let me know if you have additional queries.